ReP USP - Resultado da busca

Artigo de periodico
Leukotriene B4 licenses inflammasome activation to enhance skin host defense (2020)
Salina, Ana Carolina Guerta ; Brandt, Stephanie L.; Klopfenstein, Nathan; Blackman, Amondrea ; Bazzano, Júlia Miranda Ribeiro ; Nunes, Anderson de Sá ; Glosson, Nicole Byers ; Brodskyn, Claudia ; Tavares, Natalia Machado ; Silva, Icaro Bonyek Santos da ; Medeiros, Alexandra Ivo ; Serezani, C. Henrique
Source: Proceedings of the National Academy of Sciences. Unidades: ICB, FMRP
Subjects: IMUNOLOGIA, LEUCOTRIENOS, INFLAMAÇÃO, FAGÓCITOS, CITOCINAS, QUIMIOTAXIA, QUIMIOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALINA, Ana Carolina Guerta et al. Leukotriene B4 licenses inflammasome activation to enhance skin host defense. Proceedings of the National Academy of Sciences, v. 48, p. 30619-30627, 2020Tradução . . Disponível em: https://doi.org/10.1073/pnas.2002732117. Acesso em: 27 maio 2024.
APA
Salina, A. C. G., Brandt, S. L., Klopfenstein, N., Blackman, A., Bazzano, J. M. R., Nunes, A. de S., et al. (2020). Leukotriene B4 licenses inflammasome activation to enhance skin host defense. Proceedings of the National Academy of Sciences, 48, 30619-30627. doi:10.1073/pnas.2002732117
NLM
Salina ACG, Brandt SL, Klopfenstein N, Blackman A, Bazzano JMR, Nunes A de S, Glosson NB, Brodskyn C, Tavares NM, Silva IBS da, Medeiros AI, Serezani CH. Leukotriene B4 licenses inflammasome activation to enhance skin host defense [Internet]. Proceedings of the National Academy of Sciences. 2020 ; 48 30619-30627.[citado 2024 maio 27 ] Available from: https://doi.org/10.1073/pnas.2002732117
Vancouver
Salina ACG, Brandt SL, Klopfenstein N, Blackman A, Bazzano JMR, Nunes A de S, Glosson NB, Brodskyn C, Tavares NM, Silva IBS da, Medeiros AI, Serezani CH. Leukotriene B4 licenses inflammasome activation to enhance skin host defense [Internet]. Proceedings of the National Academy of Sciences. 2020 ; 48 30619-30627.[citado 2024 maio 27 ] Available from: https://doi.org/10.1073/pnas.2002732117
Artigo de periodico
Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial (2019)
Fassini, Priscila Giacomo ; Das, Sai Krupa; Suen, Vivian Marques Miguel; Magerowski, Greta; Marchini, Julio Sergio ; Silva Junior, Wilson Araújo da ; Changyu, Shen; Alonso-Alonso, Miguel
Source: Appetite. Unidade: FMRP
Subjects: POLIMORFISMO, NEUROTRANSMISSORES, APETITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FASSINI, Priscila Giacomo et al. Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial. Appetite, v. 140, p. 142-150, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.appet.2019.05.015. Acesso em: 27 maio 2024.
APA
Fassini, P. G., Das, S. K., Suen, V. M. M., Magerowski, G., Marchini, J. S., Silva Junior, W. A. da, et al. (2019). Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial. Appetite, 140, 142-150. doi:10.1016/j.appet.2019.05.015
NLM
Fassini PG, Das SK, Suen VMM, Magerowski G, Marchini JS, Silva Junior WA da, Changyu S, Alonso-Alonso M. Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial [Internet]. Appetite. 2019 ; 140 142-150.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.appet.2019.05.015
Vancouver
Fassini PG, Das SK, Suen VMM, Magerowski G, Marchini JS, Silva Junior WA da, Changyu S, Alonso-Alonso M. Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial [Internet]. Appetite. 2019 ; 140 142-150.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.appet.2019.05.015
Artigo de periodico
Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth (2019)
Gonçalves, Dawit Albieiro Pinheiro ; Silveira, Wilian de Assis ; Manfredi, Leandro Henrique ; Graça, Flávia A.; Armani, Andrea; Bertaggia, Enrico; O´Neill, Brian T.; Silva, Natalia Lautherbach Ennes da ; Machado, Juliano; Nogara, Leonardo; Pereira, Marcelo G.; Arcidiacono, Diletta; Realdon, Stefano; Kahn, C. Ronald; Sandri, Marco ; Kettelhut, Isis Carmo ; Navegantes, Luiz Carlos Carvalho
Source: Journal of Cachexia, Sarcopenia and Muscle. Unidade: FMRP
Subjects: INSULINA, METABOLISMO DE PROTEÍNA, MÚSCULO ESQUELÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Dawit Albieiro Pinheiro et al. Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth. Journal of Cachexia, Sarcopenia and Muscle, v. 10, n. 2, p. 455-475, 2019Tradução . . Disponível em: https://doi.org/10.1002/jcsm.12395. Acesso em: 27 maio 2024.
APA
Gonçalves, D. A. P., Silveira, W. de A., Manfredi, L. H., Graça, F. A., Armani, A., Bertaggia, E., et al. (2019). Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth. Journal of Cachexia, Sarcopenia and Muscle, 10( 2), 455-475. doi:10.1002/jcsm.12395
NLM
Gonçalves DAP, Silveira W de A, Manfredi LH, Graça FA, Armani A, Bertaggia E, O´Neill BT, Silva NLE da, Machado J, Nogara L, Pereira MG, Arcidiacono D, Realdon S, Kahn CR, Sandri M, Kettelhut IC, Navegantes LCC. Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2019 ; 10( 2): 455-475.[citado 2024 maio 27 ] Available from: https://doi.org/10.1002/jcsm.12395
Vancouver
Gonçalves DAP, Silveira W de A, Manfredi LH, Graça FA, Armani A, Bertaggia E, O´Neill BT, Silva NLE da, Machado J, Nogara L, Pereira MG, Arcidiacono D, Realdon S, Kahn CR, Sandri M, Kettelhut IC, Navegantes LCC. Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2019 ; 10( 2): 455-475.[citado 2024 maio 27 ] Available from: https://doi.org/10.1002/jcsm.12395
Artigo de periodico
Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis (2019)
Arroyo, Gianfranco; Bustos, Javier A.; Lescano, Andres G.; Gonzales, Isidro; Saavedra, Herbert; Rodriguez, Silvia; Pretell, E. Javier; Bonato, Pierina Sueli; Lanchote, Vera Lucia ; Takayanagui, Osvaldo Massaiti ; Horton, John; Gonzalez, Armando E.; Gilman, Robert H.; Garcia, Hector H.
Source: Clinical Infectious Diseases. Unidades: FCFRP, FMRP
Subjects: NEUROCISTICERCOSE, ANTIPARASITÁRIOS, ANTI-HELMÍNTICOS, CISTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARROYO, Gianfranco et al. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, v. 69, n. 11, p. 1996-2002, 2019Tradução . . Disponível em: https://doi.org/10.1093/cid/ciz085. Acesso em: 27 maio 2024.
APA
Arroyo, G., Bustos, J. A., Lescano, A. G., Gonzales, I., Saavedra, H., Rodriguez, S., et al. (2019). Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, 69( 11), 1996-2002. doi:10.1093/cid/ciz085
NLM
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2024 maio 27 ] Available from: https://doi.org/10.1093/cid/ciz085
Vancouver
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2024 maio 27 ] Available from: https://doi.org/10.1093/cid/ciz085
Artigo de periodico
Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry (2019)
Filgueira, Fernando Paranaiba; Lobato, Núbia de Souza; Nascimento, Denise L.; Ceravolo, Graziela Scalianti; Giachini, Fernanda R. C.; Lima, Victor V.; Dantas, Ana Paula; Fortes, Zuleica Bruno; Webb, R. Clinton; Tostes, Rita de Cássia Aleixo ; Carvalho, Maria Helena Catelli de
Source: Steroids. Unidades: ICB, FMRP
Subjects: ESTRADIOL, ARTÉRIAS, VASODILATAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Fernando Paranaiba et al. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. Steroids, v. 141, p. 46-54, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.steroids.2018.11.006. Acesso em: 27 maio 2024.
APA
Filgueira, F. P., Lobato, N. de S., Nascimento, D. L., Ceravolo, G. S., Giachini, F. R. C., Lima, V. V., et al. (2019). Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. Steroids, 141, 46-54. doi:10.1016/j.steroids.2018.11.006
NLM
Filgueira FP, Lobato N de S, Nascimento DL, Ceravolo GS, Giachini FRC, Lima VV, Dantas AP, Fortes ZB, Webb RC, Tostes R de CA, Carvalho MHC de. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry [Internet]. Steroids. 2019 ; 141 46-54.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.steroids.2018.11.006
Vancouver
Filgueira FP, Lobato N de S, Nascimento DL, Ceravolo GS, Giachini FRC, Lima VV, Dantas AP, Fortes ZB, Webb RC, Tostes R de CA, Carvalho MHC de. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry [Internet]. Steroids. 2019 ; 141 46-54.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.steroids.2018.11.006
Artigo de periodico
Genetic variants of HIF1α are associated with right ventricular fibrotic load in repaired tetralogy of Fallot patients: a cardiovascular magnetic resonance study (2019)
Hoang, Thanh T.; Manso, Paulo Henrique ; Edman, Sharon; Mercer-Rosa, Laura; Mitchell, Laura E.; Sewda, Anshuman; Swartz, Michael D.; Fogel, Mark A.; Agopian, A. J.; Goldmuntz, Elizabeth
Source: Journal of Cardiovascular Magnetic Resonance. Unidade: FMRP
Subjects: RESSONÂNCIA MAGNÉTICA, CARDIOPATIAS, CARDIOPATIAS CONGÊNITAS, GENÉTICA, VENTRÍCULO CARDÍACO, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOANG, Thanh T. et al. Genetic variants of HIF1α are associated with right ventricular fibrotic load in repaired tetralogy of Fallot patients: a cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance, v. 21, n. 1, p. art. 51 [10], 2019Tradução . . Disponível em: https://doi.org/10.1186/s12968-019-0555-2. Acesso em: 27 maio 2024.
APA
Hoang, T. T., Manso, P. H., Edman, S., Mercer-Rosa, L., Mitchell, L. E., Sewda, A., et al. (2019). Genetic variants of HIF1α are associated with right ventricular fibrotic load in repaired tetralogy of Fallot patients: a cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance, 21( 1), art. 51 [10]. doi:10.1186/s12968-019-0555-2
NLM
Hoang TT, Manso PH, Edman S, Mercer-Rosa L, Mitchell LE, Sewda A, Swartz MD, Fogel MA, Agopian AJ, Goldmuntz E. Genetic variants of HIF1α are associated with right ventricular fibrotic load in repaired tetralogy of Fallot patients: a cardiovascular magnetic resonance study [Internet]. Journal of Cardiovascular Magnetic Resonance. 2019 ; 21( 1): art. 51 [10].[citado 2024 maio 27 ] Available from: https://doi.org/10.1186/s12968-019-0555-2
Vancouver
Hoang TT, Manso PH, Edman S, Mercer-Rosa L, Mitchell LE, Sewda A, Swartz MD, Fogel MA, Agopian AJ, Goldmuntz E. Genetic variants of HIF1α are associated with right ventricular fibrotic load in repaired tetralogy of Fallot patients: a cardiovascular magnetic resonance study [Internet]. Journal of Cardiovascular Magnetic Resonance. 2019 ; 21( 1): art. 51 [10].[citado 2024 maio 27 ] Available from: https://doi.org/10.1186/s12968-019-0555-2
Artigo de periodico
Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines (2019)
Stur, Elaine ; Aristizábal Pachón, Andrés Felipe ; Peronni, Kamila Chagas; Agostini, Lidiane Pignaton; Waigel, Sabine; Chariker, Julia ; Miller, Donald M.; Thomas, Shelia Dian ; Rezzoug, Francine; Detogni, Raquel Spinassé ; Reis, Raquel Silva dos; Silva Junior, Wilson Araújo da ; Louro, Iúri Drumond
Source: PLOS ONE. Unidade: FMRP
Subjects: HERBICIDAS, NEOPLASIAS MAMÁRIAS, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STUR, Elaine et al. Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines. PLOS ONE, v. 14, n. 7, 2019Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0219610. Acesso em: 27 maio 2024.
APA
Stur, E., Aristizábal Pachón, A. F., Peronni, K. C., Agostini, L. P., Waigel, S., Chariker, J., et al. (2019). Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines. PLOS ONE, 14( 7). doi:10.1371/journal.pone.0219610
NLM
Stur E, Aristizábal Pachón AF, Peronni KC, Agostini LP, Waigel S, Chariker J, Miller DM, Thomas SD, Rezzoug F, Detogni RS, Reis RS dos, Silva Junior WA da, Louro ID. Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines [Internet]. PLOS ONE. 2019 ; 14( 7):[citado 2024 maio 27 ] Available from: https://doi.org/10.1371/journal.pone.0219610
Vancouver
Stur E, Aristizábal Pachón AF, Peronni KC, Agostini LP, Waigel S, Chariker J, Miller DM, Thomas SD, Rezzoug F, Detogni RS, Reis RS dos, Silva Junior WA da, Louro ID. Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines [Internet]. PLOS ONE. 2019 ; 14( 7):[citado 2024 maio 27 ] Available from: https://doi.org/10.1371/journal.pone.0219610
Artigo de periodico
Design and characterization of crotamine-functionalized gold nanoparticles (2018)
Karpel, Richard L.; Liberato, Michelle da Silva; Campeiro, Joana D.; Bergeon, Lorna; Szychowski, Brian; Butler, Andrew; Marino, Giovanni; Cusic, Joelle F.; Oliveira, Lilian Caroline Gonçalves de; Oliveira, Eduardo Brandt de; Farias, Marcelo Alexandre de; Portugal, Rodrigo Villares; Alves, Wendel Andrade; Daniel, Marie-Christine; Hayashi, Mirian A. F.
Source: Colloids and Surfaces B: Biointerfaces. Unidade: FMRP
Subjects: TOXINAS, COBRAS, POLIPEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KARPEL, Richard L. et al. Design and characterization of crotamine-functionalized gold nanoparticles. Colloids and Surfaces B: Biointerfaces, v. 163, p. 1-8, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2017.12.013. Acesso em: 27 maio 2024.
APA
Karpel, R. L., Liberato, M. da S., Campeiro, J. D., Bergeon, L., Szychowski, B., Butler, A., et al. (2018). Design and characterization of crotamine-functionalized gold nanoparticles. Colloids and Surfaces B: Biointerfaces, 163, 1-8. doi:10.1016/j.colsurfb.2017.12.013
NLM
Karpel RL, Liberato M da S, Campeiro JD, Bergeon L, Szychowski B, Butler A, Marino G, Cusic JF, Oliveira LCG de, Oliveira EB de, Farias MA de, Portugal RV, Alves WA, Daniel M-C, Hayashi MAF. Design and characterization of crotamine-functionalized gold nanoparticles [Internet]. Colloids and Surfaces B: Biointerfaces. 2018 ; 163 1-8.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.colsurfb.2017.12.013
Vancouver
Karpel RL, Liberato M da S, Campeiro JD, Bergeon L, Szychowski B, Butler A, Marino G, Cusic JF, Oliveira LCG de, Oliveira EB de, Farias MA de, Portugal RV, Alves WA, Daniel M-C, Hayashi MAF. Design and characterization of crotamine-functionalized gold nanoparticles [Internet]. Colloids and Surfaces B: Biointerfaces. 2018 ; 163 1-8.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.colsurfb.2017.12.013
Artigo de periodico
Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens (2018)
Prendergast, Emily N.; Fonseca, Marcos Abraão de Souza; Dezem, Felipe Segato; Lester, Jenny; Karlan, Beth Y.; Noushmehr, Houtan; Lin, Xianzhi; Lawrenson, Kate
Source: PLOS ONE. Unidade: FMRP
Subjects: RNA, GENÉTICA BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRENDERGAST, Emily N. et al. Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens. PLOS ONE, v. 13, n. 5, p. e0196913, 2018Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0196913. Acesso em: 27 maio 2024.
APA
Prendergast, E. N., Fonseca, M. A. de S., Dezem, F. S., Lester, J., Karlan, B. Y., Noushmehr, H., et al. (2018). Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens. PLOS ONE, 13( 5), e0196913. doi:10.1371/journal.pone.0196913
NLM
Prendergast EN, Fonseca MA de S, Dezem FS, Lester J, Karlan BY, Noushmehr H, Lin X, Lawrenson K. Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens [Internet]. PLOS ONE. 2018 ; 13( 5): e0196913.[citado 2024 maio 27 ] Available from: https://doi.org/10.1371/journal.pone.0196913
Vancouver
Prendergast EN, Fonseca MA de S, Dezem FS, Lester J, Karlan BY, Noushmehr H, Lin X, Lawrenson K. Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens [Internet]. PLOS ONE. 2018 ; 13( 5): e0196913.[citado 2024 maio 27 ] Available from: https://doi.org/10.1371/journal.pone.0196913
Artigo de periodico
Oncogenic signaling pathways in the cancer genome atlas (2018)
Sanchez-Vega, Francisco; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell. Unidade: FMRP
Subjects: GENÔMICA, NEOPLASIAS, ONCOLOGIA, TERAPÊUTICA, CICLO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANCHEZ-VEGA, Francisco et al. Oncogenic signaling pathways in the cancer genome atlas. Cell, v. 173, n. 2, p. 321-337.e1-e4, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2018.03.035. Acesso em: 27 maio 2024.
APA
Sanchez-Vega, F., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Oncogenic signaling pathways in the cancer genome atlas. Cell, 173( 2), 321-337.e1-e4. doi:10.1016/j.cell.2018.03.035
NLM
Sanchez-Vega F, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Oncogenic signaling pathways in the cancer genome atlas [Internet]. Cell. 2018 ; 173( 2): 321-337.e1-e4.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.cell.2018.03.035
Vancouver
Sanchez-Vega F, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Oncogenic signaling pathways in the cancer genome atlas [Internet]. Cell. 2018 ; 173( 2): 321-337.e1-e4.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.cell.2018.03.035
Artigo de periodico
Comprehensive characterization of cancer driver genes and mutations (2018)
Bailey, Matthew H.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell. Unidade: FMRP
Subjects: NEOPLASIAS, MUTAÇÃO, GENOMAS, BIOINFORMÁTICA, ENTROPIA, ALGORITMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAILEY, Matthew H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell, v. 173, n. 2, p. 371-385.e1-e9, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2018.02.060. Acesso em: 27 maio 2024.
APA
Bailey, M. H., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Comprehensive characterization of cancer driver genes and mutations. Cell, 173( 2), 371-385.e1-e9. doi:10.1016/j.cell.2018.02.060
NLM
Bailey MH, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Comprehensive characterization of cancer driver genes and mutations [Internet]. Cell. 2018 ; 173( 2): 371-385.e1-e9.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.cell.2018.02.060
Vancouver
Bailey MH, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Comprehensive characterization of cancer driver genes and mutations [Internet]. Cell. 2018 ; 173( 2): 371-385.e1-e9.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.cell.2018.02.060
Artigo de periodico
Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas (2018)
Campbell, Joshua D.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Reports. Unidade: FMRP
Subjects: GENÔMICA, CARCINOMA DE CÉLULAS ESCAMOSAS, PROTEÔMICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPBELL, Joshua D. et al. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas. Cell Reports, v. 23, n. 1, p. 194-212.e1-e6, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2018.03.063. Acesso em: 27 maio 2024.
APA
Campbell, J. D., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas. Cell Reports, 23( 1), 194-212.e1-e6. doi:10.1016/j.celrep.2018.03.063
NLM
Campbell JD, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas [Internet]. Cell Reports. 2018 ; 23( 1): 194-212.e1-e6.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.063
Vancouver
Campbell JD, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas [Internet]. Cell Reports. 2018 ; 23( 1): 194-212.e1-e6.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.063
Artigo de periodico
Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context (2018)
Chiu, Hua-Sheng; Somvanshi, Sonal; Patel, Ektaben; Chen, Ting-Wen; Singh, Vivek P.; Zorman, Barry; Patil, Sagar L.; Pan, Yinghong; Chatterjee, Sujash S.; Sood, Anil K.; Gunaratne, Preethi H.; Sumazin, Pavel; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankuty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Reports. Unidade: FMRP
Subjects: NEOPLASIAS PANCREÁTICAS, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHIU, Hua-Sheng et al. Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context. Cell Reports, v. 23, n. 1, p. 297-312, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2018.03.064. Acesso em: 27 maio 2024.
APA
Chiu, H. -S., Somvanshi, S., Patel, E., Chen, T. -W., Singh, V. P., Zorman, B., et al. (2018). Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context. Cell Reports, 23( 1), 297-312. doi:10.1016/j.celrep.2018.03.064
NLM
Chiu H-S, Somvanshi S, Patel E, Chen T-W, Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS, Sood AK, Gunaratne PH, Sumazin P, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context [Internet]. Cell Reports. 2018 ; 23( 1): 297-312.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.064
Vancouver
Chiu H-S, Somvanshi S, Patel E, Chen T-W, Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS, Sood AK, Gunaratne PH, Sumazin P, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankuty AK, Tirapelli DP da C. Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context [Internet]. Cell Reports. 2018 ; 23( 1): 297-312.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.064
Artigo de periodico
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia (2018)
Gomes, Felipe Villela ; Edelson, Jessica R.; Volk, David W.; Grace, Anthony A.
Source: Schizophrenia Research. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, CÉREBRO, CRESCIMENTO E DESENVOLVIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela et al. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, v. 201, p. 254-260, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2018.04.030. Acesso em: 27 maio 2024.
APA
Gomes, F. V., Edelson, J. R., Volk, D. W., & Grace, A. A. (2018). Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, 201, 254-260. doi:10.1016/j.schres.2018.04.030
NLM
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030
Vancouver
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 maio 27 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030
Artigo de periodico
Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 (2018)
Lisboa, Sabrina Francesca; Niraula, Anzela; Resstel, Leonardo Barbosa Moraes; Guimarães, Francisco Silveira; Godbout, Jonathan P.; Sheridan, John F.
Source: Neuropsychopharmacology. Unidade: FMRP
Subjects: CANABINOIDES, ANSIEDADE, MEDO, NEUROFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, Sabrina Francesca et al. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. Neuropsychopharmacology, v. 43, n. 9, p. 1924-1933, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41386-018-0064-2. Acesso em: 27 maio 2024.
APA
Lisboa, S. F., Niraula, A., Resstel, L. B. M., Guimarães, F. S., Godbout, J. P., & Sheridan, J. F. (2018). Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. Neuropsychopharmacology, 43( 9), 1924-1933. doi:10.1038/s41386-018-0064-2
NLM
Lisboa SF, Niraula A, Resstel LBM, Guimarães FS, Godbout JP, Sheridan JF. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 [Internet]. Neuropsychopharmacology. 2018 ; 43( 9): 1924-1933.[citado 2024 maio 27 ] Available from: https://doi.org/10.1038/s41386-018-0064-2
Vancouver
Lisboa SF, Niraula A, Resstel LBM, Guimarães FS, Godbout JP, Sheridan JF. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 [Internet]. Neuropsychopharmacology. 2018 ; 43( 9): 1924-1933.[citado 2024 maio 27 ] Available from: https://doi.org/10.1038/s41386-018-0064-2
Artigo de periodico
SOCS1 is a negative regulator of metabolic reprogramming during sepsis (2017)
Piñeros Alvarez, Annie Rocio; Glosson-Byers, Nicole; Brandt, Stephanie; Wang, Soujuan; Wong, Hector; Sturgeon, Sarah; McCarthy, Brian Paul; Territo, Paul R.; Alves Filho, José Carlos Farias; Serezani, Carlos Henrique
Source: JCI Insight. Unidade: FMRP
Assunto: SEPSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIÑEROS ALVAREZ, Annie Rocio et al. SOCS1 is a negative regulator of metabolic reprogramming during sepsis. JCI Insight, v. 2, n. 13, 2017Tradução . . Disponível em: https://doi.org/10.1172/jci.insight.92530. Acesso em: 27 maio 2024.
APA
Piñeros Alvarez, A. R., Glosson-Byers, N., Brandt, S., Wang, S., Wong, H., Sturgeon, S., et al. (2017). SOCS1 is a negative regulator of metabolic reprogramming during sepsis. JCI Insight, 2( 13). doi:10.1172/jci.insight.92530
NLM
Piñeros Alvarez AR, Glosson-Byers N, Brandt S, Wang S, Wong H, Sturgeon S, McCarthy BP, Territo PR, Alves Filho JCF, Serezani CH. SOCS1 is a negative regulator of metabolic reprogramming during sepsis [Internet]. JCI Insight. 2017 ; 2( 13):[citado 2024 maio 27 ] Available from: https://doi.org/10.1172/jci.insight.92530
Vancouver
Piñeros Alvarez AR, Glosson-Byers N, Brandt S, Wang S, Wong H, Sturgeon S, McCarthy BP, Territo PR, Alves Filho JCF, Serezani CH. SOCS1 is a negative regulator of metabolic reprogramming during sepsis [Internet]. JCI Insight. 2017 ; 2( 13):[citado 2024 maio 27 ] Available from: https://doi.org/10.1172/jci.insight.92530
Artigo de periodico
A novel peptide that improves metabolic parameters without adverse central nervous system effects (2017)
Reckziegel, Patricia ; Festuccia, William Tadeu Lara ; Britto, Luiz Roberto Giorgetti de ; Heimann, Joel Cláudio ; Guimarães, Francisco Silveira ; Eichler, Rosangela Aparecida dos Santos ; Ferro, Emer Suavinho
Source: Scientific reports. Unidades: ICB, FM, FMRP
Subjects: PEPTÍDEOS, METABOLISMO, SISTEMA NERVOSO CENTRAL, FARMACOLOGIA, FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RECKZIEGEL, Patricia et al. A novel peptide that improves metabolic parameters without adverse central nervous system effects. Scientific reports, v. 7, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-13690-9. Acesso em: 27 maio 2024.
APA
Reckziegel, P., Festuccia, W. T. L., Britto, L. R. G. de, Heimann, J. C., Guimarães, F. S., Eichler, R. A. dos S., & Ferro, E. S. (2017). A novel peptide that improves metabolic parameters without adverse central nervous system effects. Scientific reports, 7. doi:10.1038/s41598-017-13690-9
NLM
Reckziegel P, Festuccia WTL, Britto LRG de, Heimann JC, Guimarães FS, Eichler RA dos S, Ferro ES. A novel peptide that improves metabolic parameters without adverse central nervous system effects [Internet]. Scientific reports. 2017 ; 7[citado 2024 maio 27 ] Available from: https://doi.org/10.1038/s41598-017-13690-9
Vancouver
Reckziegel P, Festuccia WTL, Britto LRG de, Heimann JC, Guimarães FS, Eichler RA dos S, Ferro ES. A novel peptide that improves metabolic parameters without adverse central nervous system effects [Internet]. Scientific reports. 2017 ; 7[citado 2024 maio 27 ] Available from: https://doi.org/10.1038/s41598-017-13690-9

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration